Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 166

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease

Open access
Smid, Bouwien E, van der Tol, Linda, Biegstraaten, Marieke, Linthorst, Gabor E, Hollak, Carla E M, Poorthuis, Ben J H M · 2015 · Journal of Medical Genetics

Abstract

Background: Fabry disease (FD), a lysosomal storage disorder caused by α-galactosidase A (GLA) gene variants, has a heterogeneous phenotype. GLA variants can lead to classical FD, an attenuated non-classical phenotype, or no disease at all. This study investigates the value of plasma globotriaosylsphingosine (lysoGb3) to distinguish between these groups. This is of particular importance in the diagnosis of individuals with a GLA variant and an uncertain diagnosis of FD, lacking characteristic features of classical FD. Methods: Subjects with GLA variants were grouped as classical, non-classical, uncertain or no FD, using strict phenotypical, biochemical and histological criteria. Plasma lysoGb3 was assessed by LC/MS/MS (normal ≤0.6 nmol/L). Results: 154 subjects were grouped into classical (38 males (M), 66 females (F)), non-classical (13M, 14F), uncertain (5M, 9F) or no FD (6M, 3F). All subjects with a classical phenotype had elevated lysoGb3 values (M: range 45–150, F: 1.5–41.5). LysoGb3 values in patients with a non-classical phenotype (M: 1.3–35.7, F: 0.5–2.0) were different from healthy controls (M: p<0.01, F: p<0.05), but females overlapped with controls. In the no-FD group, lysoGb3 was normal. Conclusions: LysoGb3 is a reliable diagnostic tool to discern classical FD from subjects without FD. This study suggests that the same applies to patients with a non-classical phenotype. LysoGb3 values of female patients overlap with controls. Consequently, in uncertain cases, increased lysoGb3 values are very suggestive for FD, but normal values cannot exclude FD. Confirmation in larger cohorts and data on the specificity of small lysoGb3 increases are necessary.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/jmedgenet-2014-102872

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 166

Metadata

Authors
Smid, B. E., van der Tol, L., Biegstraaten, M., Linthorst, G. E., Hollak, C. E. M., & Poorthuis, B. J. H. M.
Venue
Journal of Medical Genetics
Publisher
BMJ
Published
2015-01-16
Volume
52
Issue
4
Pages
262-268
ISSN
  • 0022-2593 (ISSN-L)
  • 1468-6244
OpenAlex
W2053639086
Cited by
166
References
1
FWCI
11.62
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. https://app.cochat.ai/papers/10.1136/jmedgenet-2014-102872
The paper
Smid, B. E., van der Tol, L., Biegstraaten, M., Linthorst, G. E., Hollak, C. E. M., & Poorthuis, B. J. H. M. (2015). Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease. Journal of Medical Genetics. https://doi.org/10.1136/jmedgenet-2014-102872

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.